Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia

• Phase 2, open-label, multicentre, single-arm study to evaluate the activity of the combination of EGFR inhibitors and c-MET inhibitors in pa… Pending
  2024-518892-72-00 Phase II 1 country
• Stereotactic body radiation therapy on Prostate with or without Androgen deprivation therapy, a phase III randomized controlled trial (SPA T… Pending
  2024-520093-34-00 Phase III 1 country BICALUTAMIDE; TRIPTORELIN
• PROSPECTIVE, PHASE II STUDY TO EVALUATE THE EFFICACY OF ADDITION OF PROGESTERONE TO STANDARD CHEMOTHERAPY ACCORDING TO EDP SCHEME PLUS MITOT… Pending
  2024-520160-34-00 Phase II 1 country MEGESTROL ACETATE
• Prospective Phase II study on Safety and Efficacy of Fludarabine plus Treosulfan (14g) (FT14) conditioning regimen for allogeneic Stem Cell … Pending
  2024-520326-11-00 Phase II 1 country ANTI-T LYMPHOCYTE IMMUNOGLOBULIN FOR HUMAN USE, RABBIT; FLUDARABINE PHOSPHATE; T…
• Randomized Multicentric Proof-of-Concept Phase 2 Trial Doravirine in the Early Outpatient Management of West Nile Virus Infection in Patien… Pending
  2025-521677-14-00 Phase II 1 country DORAVIRINE
• Efficacy of cell therapy with allo-MSCs in patients with gvhd resistant to ruxolitinib second line therapy: a Phase IIB Clinical Trial - MSC… Pending
  2025-523448-10-00 Phase II 1 country MESENCHYMAL STROMAL CELLS, EX VIVO CULTURED
• Cemiplimab maintenance treatment for advanced adrenocortical cancer Recruiting
  2024-520449-21-00 Phase II 1 country CEMIPLIMAB; MITOTANE
• Adjuvant therapy in high risk adrenocortical carcinoma (ADIUVO-2) Recruiting
  2022-500013-32-01 Phase III 3 countries

Showing 1–8 of 8 trials